IL132848A - תכשיר לטיפול בשחמת הפטית - Google Patents

תכשיר לטיפול בשחמת הפטית

Info

Publication number
IL132848A
IL132848A IL13284898A IL13284898A IL132848A IL 132848 A IL132848 A IL 132848A IL 13284898 A IL13284898 A IL 13284898A IL 13284898 A IL13284898 A IL 13284898A IL 132848 A IL132848 A IL 132848A
Authority
IL
Israel
Prior art keywords
halofuginone
group
collagen
liver
hepatic
Prior art date
Application number
IL13284898A
Other languages
English (en)
Other versions
IL132848A0 (en
Original Assignee
Israel State
Hadasit Med Res Service
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25338371&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL132848(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Israel State, Hadasit Med Res Service filed Critical Israel State
Publication of IL132848A0 publication Critical patent/IL132848A0/xx
Publication of IL132848A publication Critical patent/IL132848A/he

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL13284898A 1997-05-23 1998-05-22 תכשיר לטיפול בשחמת הפטית IL132848A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86238297A 1997-05-23 1997-05-23
PCT/US1998/010505 WO1998052514A2 (en) 1997-05-23 1998-05-22 Treatment of hepatic cirrhosis

Publications (2)

Publication Number Publication Date
IL132848A0 IL132848A0 (en) 2001-03-19
IL132848A true IL132848A (he) 2004-08-31

Family

ID=25338371

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13284898A IL132848A (he) 1997-05-23 1998-05-22 תכשיר לטיפול בשחמת הפטית

Country Status (8)

Country Link
EP (1) EP1014988A2 (he)
JP (1) JP2002515905A (he)
KR (1) KR100540537B1 (he)
CN (1) CN1160073C (he)
AU (1) AU748754B2 (he)
CA (1) CA2290502C (he)
IL (1) IL132848A (he)
WO (1) WO1998052514A2 (he)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004039308A2 (en) * 2002-10-31 2004-05-13 State Of Israel, Ministry Of Agriculture Quinazolinone compositions for regulation of gene expression related to pathological processes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3320124A (en) * 1964-07-20 1967-05-16 American Cyanamid Co Method for treating coccidiosis with quinazolinones
CA2113229C (en) * 1994-01-11 1999-04-20 Mark Pines Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof

Also Published As

Publication number Publication date
KR100540537B1 (ko) 2006-01-10
CN1160073C (zh) 2004-08-04
KR20010012838A (ko) 2001-02-26
CA2290502A1 (en) 1998-11-26
CA2290502C (en) 2007-08-28
EP1014988A2 (en) 2000-07-05
AU7692298A (en) 1998-12-11
IL132848A0 (en) 2001-03-19
AU748754B2 (en) 2002-06-13
WO1998052514A3 (en) 1999-08-19
CN1265034A (zh) 2000-08-30
WO1998052514A2 (en) 1998-11-26
JP2002515905A (ja) 2002-05-28

Similar Documents

Publication Publication Date Title
IL131348A (en) Composition for treatment and prevention of adhesions
US20060194822A1 (en) Treatment for renal fibrosis
WO2000064470A1 (en) A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
US6562829B1 (en) Treatment of hepatic cirrhosis
SK288707B6 (sk) Farmaceutické kombinácie obsahujúce antagonistu P2T receptora a ďalšie antitrombotické činidlá, spôsob ich prípravy a ich použitie na liečenie a prevenciu trombózy
CA2568436A1 (en) Combination therapy comprising an adenosine a1 receptor antagonist and an aldosterone inhibitor
JP2002509540A (ja) アルドースレダクターゼ阻害剤およびace阻害剤を含有する医薬組成物
US20220378754A1 (en) Compositions and methods for treating slow-flow vascular malformations
JP2003503457A (ja) 心臓血管合併症の治療用薬剤の製造におけるアンギオテンシンii1型受容体アンタゴニストの使用
CA2290502C (en) Treatment of hepatic cirrhosis
US5872124A (en) Treatment of diseases of the central nervous system using uric acid as a scavenger of peroxynitrite
AU2002309211A1 (en) Treatment of renal fibrosis
US7439077B2 (en) Coumarin analog compounds for safer anticoagulant treatment
US20140288102A1 (en) Prevention of recurrences of urethral strictures following conventional therapy
CA2285350A1 (en) Treatment for pulmonary fibrosis
WO1998034616A1 (en) Treatment of skin disorders
Mima et al. Therapeutic dose and timing of administration of RNA synthesis inhibitors for preventing cerebral vasospasm after subarachnoid hemorrhage
US20160166577A1 (en) Treatment of pulmonary fibrosis using an inhibitor of cbp/catenin
AU2008201290B2 (en) Therapeutic treatment
US20040068006A1 (en) Method for preventing acute renal failure
Whayne Women and cardiovascular disease—Prevention of heart disease
WO2001097798A1 (en) Method for the prevention or reduction of cardiovascular events associated with coronary intervention
WO2002056941A2 (en) Method for the treatment of peripheral vascular disease
HU226244B1 (hu) Gyógyszer-kombináció a diabétesz megelõzésére vagy kezelésére

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired